General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer.

ABSTRACT:

Background

In New Zealand (NZ), lung cancer disproportionately affects our indigenous Māori population, with both incidence and mortality being three times higher than NZ Europeans. Incidence of endothelial growth factor receptor (EGFR) mutated lung cancer is two to three times higher in Māori, Pacific and Asian people compared to NZ Europeans. Outcomes could potentially be improved if testing was augmented by biomarker testing of circulating tumour deoxyribonucleic acid (ctDNA) at the outset of diagnosis. Testing as a liquid biopsy could be more accessible, faster, and lower cost compared to tissue biopsy.We aimed to evaluate NZ General Practitioners' (GPs') attitudes towards liquid biopsy.

Methods

A survey was conducted of NZ GPs and was distributed through online c

SUBMITTER: Lo D 

PROVIDER: S-EPMC12799498 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature